Nusantara Vaccine Initially Developed in the US, Tested in Indonesia, Says Covid-19 Task Force
As the locally-developed Covid-19 vaccine known as Nusantara Vaccine remain controversial, a spokesman for the National Covid-19 Task Force Wiku Adisasmito said the vaccine was initially developed in the US, but the clinical tests were done in Indonesia.
"The Nusantara Vaccine is a type of vaccine that was initially developed in the US, while the clinical tests were conducted in Indonesia," Wiku told a streamed news conference on Thursday, April 15.
In principle, he said, all vaccines that are meant for the public must obtain permission from Indonesia’s Food and Drug Agency (BPOM) to ensure their safety, efficacy, and feasibility aspects.
Wiku added as long as all the criteria are met, the government will provide support for the development of the Nusantara Vaccine.
It was reported that the Nusantara vaccine which was initiated by former Health Minister Terawan Agus Putranto came under the spotlight again.
BPOM decided to halt testing of the Nusantara vaccine at the second and third clinical stages last month after it determined that the vaccine does not meet ethical standards on good clinical practice, as well as discrepancies of data on its efficacy.
Dapatkan update berita pilihan dan breaking news setiap hari dari Kompas.com. Mari bergabung di Grup Telegram "Kompas.com News Update", caranya klik link https://t.me/kompascomupdate, kemudian join. Anda harus install aplikasi Telegram terlebih dulu di ponsel.